Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer.

Ma F, Guan Y, Yi Z, Chang L, Li Q, Chen S, Zhu W, Guan X, Li C, Qian H, Xia X, Yang L, Zhang J, Husain H, Liao Z, Futreal A, Huang J, Yi X, Xu B.

Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32536. [Epub ahead of print]

PMID:
31241775
2.
3.

Genome-wide cell-free DNA fragmentation in patients with cancer.

Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, Marrone K, Brahmer J, Woodward BD, Husain H, van Rooijen KL, Ørntoft MW, Madsen AH, van de Velde CJH, Verheij M, Cats A, Punt CJA, Vink GR, van Grieken NCT, Koopman M, Fijneman RJA, Johansen JS, Nielsen HJ, Meijer GA, Andersen CL, Scharpf RB, Velculescu VE.

Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29.

PMID:
31142840
4.

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer.

Wang Y, Zhao C, Chang L, Jia R, Liu R, Zhang Y, Gao X, Li J, Chen R, Xia X, Bulbul A, Husain H, Guan Y, Yi X, Xu J.

EBioMedicine. 2019 May;43:261-269. doi: 10.1016/j.ebiom.2019.04.003. Epub 2019 Apr 25.

5.

Prevalence, Risk Factors, and Fetomaternal Outcomes of Gestational Diabetes Mellitus in Kuwait: A Cross-Sectional Study.

Groof Z, Garashi G, Husain H, Owayed S, AlBader S, Mouhsen H, Mohammad A, Ziyab AH.

J Diabetes Res. 2019 Mar 3;2019:9136250. doi: 10.1155/2019/9136250. eCollection 2019.

6.

Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer.

Murtuza A, Bulbul A, Shen JP, Keshavarzian P, Woodward BD, Lopez-Diaz FJ, Lippman SM, Husain H.

Cancer Res. 2019 Feb 15;79(4):689-698. doi: 10.1158/0008-5472.CAN-18-1281. Epub 2019 Feb 4. Review.

PMID:
30718357
7.

Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer.

Phallen J, Leal A, Woodward BD, Forde PM, Naidoo J, Marrone KA, Brahmer JR, Fiksel J, Medina JE, Cristiano S, Palsgrove DN, Gocke CD, Bruhm DC, Keshavarzian P, Adleff V, Weihe E, Anagnostou V, Scharpf RB, Velculescu VE, Husain H.

Cancer Res. 2019 Mar 15;79(6):1204-1213. doi: 10.1158/0008-5472.CAN-18-1082. Epub 2018 Dec 20.

8.

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.

Marcoux N, Gettinger SN, O'Kane G, Arbour KC, Neal JW, Husain H, Evans TL, Brahmer JR, Muzikansky A, Bonomi PD, Del Prete S, Wurtz A, Farago AF, Dias-Santagata D, Mino-Kenudson M, Reckamp KL, Yu HA, Wakelee HA, Shepherd FA, Piotrowska Z, Sequist LV.

J Clin Oncol. 2019 Feb 1;37(4):278-285. doi: 10.1200/JCO.18.01585. Epub 2018 Dec 14.

PMID:
30550363
9.

Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.

Oxnard GR, Hu Y, Mileham KF, Husain H, Costa DB, Tracy P, Feeney N, Sholl LM, Dahlberg SE, Redig AJ, Kwiatkowski DJ, Rabin MS, Paweletz CP, Thress KS, Jänne PA.

JAMA Oncol. 2018 Nov 1;4(11):1527-1534. doi: 10.1001/jamaoncol.2018.2969.

PMID:
30073261
10.
11.

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

Bulbul A, Husain H.

Front Oncol. 2018 Apr 10;8:94. doi: 10.3389/fonc.2018.00094. eCollection 2018. Review.

12.

Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer.

Bulbul A, Forde PM, Murtuza A, Woodward B, Yang H, Bastian I, Ferguson PK, Lopez-Diaz F, Ettinger DS, Husain H.

Oncology (Williston Park). 2018 Apr 15;32(4):156-63. Review.

13.

Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis.

Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM.

Int J Biol Macromol. 2018 May;111:379-392. doi: 10.1016/j.ijbiomac.2017.12.168. Epub 2018 Jan 5. Review.

PMID:
29309868
14.

Desmoplastic Small Round Blue Cell Tumor: A Review of Treatment and Potential Therapeutic Genomic Alterations.

Bulbul A, Fahy BN, Xiu J, Rashad S, Mustafa A, Husain H, Hayes-Jordan A.

Sarcoma. 2017;2017:1278268. doi: 10.1155/2017/1278268. Epub 2017 Nov 1. Review.

15.

Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.

Hovelson DH, Liu CJ, Wang Y, Kang Q, Henderson J, Gursky A, Brockman S, Ramnath N, Krauss JC, Talpaz M, Kandarpa M, Chugh R, Tuck M, Herman K, Grasso CS, Quist MJ, Feng FY, Haakenson C, Langmore J, Kamberov E, Tesmer T, Husain H, Lonigro RJ, Robinson D, Smith DC, Alva AS, Hussain MH, Chinnaiyan AM, Tewari M, Mills RE, Morgan TM, Tomlins SA.

Oncotarget. 2017 Sep 22;8(52):89848-89866. doi: 10.18632/oncotarget.21163. eCollection 2017 Oct 27.

16.

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.

Blakely CM, Watkins TBK, Wu W, Gini B, Chabon JJ, McCoach CE, McGranahan N, Wilson GA, Birkbak NJ, Olivas VR, Rotow J, Maynard A, Wang V, Gubens MA, Banks KC, Lanman RB, Caulin AF, St John J, Cordero AR, Giannikopoulos P, Simmons AD, Mack PC, Gandara DR, Husain H, Doebele RC, Riess JW, Diehn M, Swanton C, Bivona TG.

Nat Genet. 2017 Dec;49(12):1693-1704. doi: 10.1038/ng.3990. Epub 2017 Nov 6.

17.

Cancer DNA in the Circulation: The Liquid Biopsy.

Husain H, Velculescu VE.

JAMA. 2017 Oct 3;318(13):1272-1274. doi: 10.1001/jama.2017.12131. Review. No abstract available.

18.

Direct detection of early-stage cancers using circulating tumor DNA.

Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, Parpart-Li S, Riley D, Nesselbush M, Sengamalay N, Georgiadis A, Li QK, Madsen MR, Mortensen FV, Huiskens J, Punt C, van Grieken N, Fijneman R, Meijer G, Husain H, Scharpf RB, Diaz LA Jr, Jones S, Angiuoli S, Ørntoft T, Nielsen HJ, Andersen CL, Velculescu VE.

Sci Transl Med. 2017 Aug 16;9(403). pii: eaan2415. doi: 10.1126/scitranslmed.aan2415.

PMID:
28814544
19.

Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.

Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R.

Clin Cancer Res. 2017 Sep 1;23(17):5101-5111. doi: 10.1158/1078-0432.CCR-16-2497. Epub 2017 May 24.

20.

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology.

Husain H, Nykin D, Bui N, Quan D, Gomez G, Woodward B, Venkatapathy S, Duttagupta R, Fung E, Lippman SM, Kurzrock R.

Mol Cancer Ther. 2017 May;16(5):948-955. doi: 10.1158/1535-7163.MCT-16-0436.

21.

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine.

Husain H, Melnikova VO, Kosco K, Woodward B, More S, Pingle SC, Weihe E, Park BH, Tewari M, Erlander MG, Cohen E, Lippman SM, Kurzrock R.

Clin Cancer Res. 2017 Aug 15;23(16):4716-4723. doi: 10.1158/1078-0432.CCR-17-0454. Epub 2017 Apr 18.

22.

Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer.

Yeung KT, More S, Woodward B, Velculescu V, Husain H.

Mol Diagn Ther. 2017 Aug;21(4):375-384. doi: 10.1007/s40291-017-0260-5. Review.

PMID:
28337711
23.

Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer.

Husain H, Scur M, Murtuza A, Bui N, Woodward B, Kurzrock R.

Mol Cancer Ther. 2017 Feb;16(2):265-272. doi: 10.1158/1535-7163.MCT-16-0105. Review.

24.

Radiological impact of NORM generated by oil and gas industries in the kingdom of Bahrain.

Husain H, Sakhnini L.

J Environ Radioact. 2017 Feb;167:127-133. doi: 10.1016/j.jenvrad.2016.12.004. Epub 2016 Dec 18.

PMID:
27998628
25.

New Targets in Non-Small Cell Lung Cancer.

Park SJ, More S, Murtuza A, Woodward BD, Husain H.

Hematol Oncol Clin North Am. 2017 Feb;31(1):113-129. doi: 10.1016/j.hoc.2016.08.010. Review.

PMID:
27912827
26.

Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients.

Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Patel SP, Harismendy O, Ikeda M, Parker BA, Kurzrock R.

Clin Cancer Res. 2016 Nov 15;22(22):5497-5505. doi: 10.1158/1078-0432.CCR-16-0318. Epub 2016 May 16.

27.

Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.

Bui N, Woodward B, Johnson A, Husain H.

Curr Treat Options Oncol. 2016 May;17(5):25. doi: 10.1007/s11864-016-0400-x. Review.

PMID:
27085533
28.

A Secure and Robust Compressed Domain Video Steganography for Intra- and Inter-Frames Using Embedding-Based Byte Differencing (EBBD) Scheme.

Idbeaa T, Abdul Samad S, Husain H.

PLoS One. 2016 Mar 10;11(3):e0150732. doi: 10.1371/journal.pone.0150732. eCollection 2016.

29.

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.

Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Banks KC, Lanman RB, Talasaz A, Parker BA, Kurzrock R.

Oncotarget. 2016 Mar 1;7(9):9707-17. doi: 10.18632/oncotarget.7110.

30.

Is Smoking Shisha Safer than Cigarettes: Comparison of Health Effects of Shisha and Cigarette Smoking among Young Adults in Kuwait.

Husain H, Al-Fadhli F, Al-Olaimi F, Al-Duraie A, Qureshi A, Al-Kandari W, Mitra AK.

Med Princ Pract. 2016;25(2):117-22. doi: 10.1159/000442417. Epub 2015 Nov 13.

31.

An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman SM, Desgrosellier JS, Anand S, Weis SM, Cheresh DA.

Nat Cell Biol. 2014 May;16(5):457-68. doi: 10.1038/ncb2953. Epub 2014 Apr 20.

32.

Hepatoprotective activity of methanol extract of Melastoma malabathricum leaf in rats.

Kamisan FH, Yahya F, Ismail NA, Din SS, Mamat SS, Zabidi Z, Zainulddin WN, Mohtarrudin N, Husain H, Ahmad Z, Zakaria ZA.

J Acupunct Meridian Stud. 2013 Feb;6(1):52-5. doi: 10.1016/j.jams.2012.08.002. Epub 2012 Aug 16.

33.

Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.

Husain H, Psyrri A, Markovic A, Rampias T, Pectasides E, Wang H, Slebos R, Yarbrough WG, Burtness B, Chung CH.

Laryngoscope. 2012 Dec;122(12):2762-8. doi: 10.1002/lary.23647. Epub 2012 Oct 19.

34.

Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas.

Husain H, Savage W, Grossman SA, Ye X, Burger PC, Everett A, Bettegowda C, Diaz LA Jr, Blair C, Romans KE, Holdhoff M.

J Neurooncol. 2012 Aug;109(1):123-7. doi: 10.1007/s11060-012-0874-8. Epub 2012 Apr 11.

35.

ALK-targeted therapy for lung cancer: ready for prime time.

Husain H, Rudin CM.

Oncology (Williston Park). 2011 Jun;25(7):597-601. Review.

36.

Radiotherapy in small-cell lung cancer.

Husain H, Hann C, Hales R.

Oncology (Williston Park). 2010 Oct;24(11):1047, 1049.

37.

Ethnomedical survey of plants used by the Orang Asli in Kampung Bawong, Perak, West Malaysia.

Samuel AJ, Kalusalingam A, Chellappan DK, Gopinath R, Radhamani S, Husain HA, Muruganandham V, Promwichit P.

J Ethnobiol Ethnomed. 2010 Feb 7;6:5. doi: 10.1186/1746-4269-6-5.

38.

In vitro screening of anti-lice activity of Pongamia pinnata leaves.

Anbu Jeba Sunilson JS, Suraj R, Rejitha G, Anandarajagopal K, Vimala AG, Husain HA.

Korean J Parasitol. 2009 Dec;47(4):377-80. doi: 10.3347/kjp.2009.47.4.377. Epub 2009 Dec 2.

39.

Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.

Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, Zhang W, Ning Y, Manegold PC, El-Khoueiry A, Iqbal S, Tang LH, Shah MA, Lenz HJ.

Ann Oncol. 2010 Jan;21(1):78-86. doi: 10.1093/annonc/mdp280. Epub 2009 Jul 21.

40.

Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab.

Lurje G, Nagashima F, Zhang W, Yang D, Chang HM, Gordon MA, El-Khoueiry A, Husain H, Wilson PM, Ladner RD, Mauro DJ, Langer C, Rowinsky EK, Lenz HJ.

Clin Cancer Res. 2008 Dec 1;14(23):7884-95. doi: 10.1158/1078-0432.CCR-07-5165.

41.

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.

Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ.

Pharmacogenet Genomics. 2009 Feb;19(2):95-102. doi: 10.1097/FPC.0b013e32831a9ad1.

PMID:
18987561
42.

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.

Lurje G, Zhang W, Schultheis AM, Yang D, Groshen S, Hendifar AE, Husain H, Gordon MA, Nagashima F, Chang HM, Lenz HJ.

Ann Oncol. 2008 Oct;19(10):1734-41. doi: 10.1093/annonc/mdn368. Epub 2008 Jun 11.

43.

Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer.

Lurje G, Zhang W, Yang D, Groshen S, Hendifar AE, Husain H, Nagashima F, Chang HM, Fazzone W, Ladner RD, Pohl A, Ning Y, Iqbal S, El-Khoueiry A, Lenz HJ.

Pharmacogenet Genomics. 2008 Feb;18(2):161-8. doi: 10.1097/FPC.0b013e3282f4aea6.

PMID:
18192902
44.

Use of chemical coagulants to control fouling potential for wastewater membrane bioreactor processes.

Fan F, Zhou H, Husain H.

Water Environ Res. 2007 Sep;79(9):952-7.

PMID:
17910362
45.

Comparison of mixed liquor filterability measured with bench and pilot-scale membrane bioreactors.

Nywening JP, Zhou H, Husain H.

Water Sci Technol. 2007;56(6):155-62.

PMID:
17898454
46.

Toward a high-rate enhanced biological phosphorus removal process in a membrane-assisted bioreactor.

Monti A, Hall ER, Koch FA, Dawson RN, Husain H, Kelly HG.

Water Environ Res. 2007 Jun;79(6):675-86.

PMID:
17605336
47.
48.

Comparative study of biological nutrient removal (BNR) processes with sedimentation and membrane-based separation.

Monti A, Hall ER, Dawson RN, Husain H, Kelly HG.

Biotechnol Bioeng. 2006 Jul 5;94(4):740-52.

PMID:
16477659
49.

Case report: community rehabilitation for a patient with incomplete spinal cord lesion.

Husain H, Kelleher S.

Physiother Res Int. 2005;10(4):227-31.

PMID:
16411618
50.

Identification of wastewater sludge characteristics to predict critical flux for membrane bioreactor processes.

Fan F, Zhou H, Husain H.

Water Res. 2006 Jan;40(2):205-12. Epub 2005 Dec 19.

PMID:
16360725

Supplemental Content

Loading ...
Support Center